OneMedNet Corp has successfully regained compliance with Nasdaq's minimum bid price requirement, a crucial step for the company’s continued presence on the Nasdaq Capital Market. The company received a notice from Nasdaq on October 13, 2026, confirming that it met the necessary criteria after its stock price remained above $1.00 for ten consecutive business days.
This compliance is significant for OneMedNet as it allows the company to continue operating without the threat of delisting, which can severely impact investor confidence and market perception. The notice from Nasdaq indicated that OneMedNet's common stock bid price had met the required threshold, thus closing the matter.
Background
OneMedNet Corp, classified under the SIC code 8731, operates in the services sector, specifically focusing on commercial physical and biological research. The company trades on the Nasdaq under the ticker symbols ONMD and ONMDW. As an emerging growth company, OneMedNet has been navigating the complexities of maintaining its listing while pursuing its business objectives.
What the Filing Says
The recent filing details that on October 13, 2026, OneMedNet received written confirmation from Nasdaq that it had regained compliance with the Bid Price Rule. The notice stated, "for 10 consecutive business days from September 29, 2026, through October 12, 2026, the closing bid price of the Company’s common stock was at least $1.00 per share." This compliance is now considered closed.
Impact
This development affects OneMedNet's stakeholders, including its investors and employees, who can now operate with a sense of stability regarding the company's market position. Additionally, the compliance may influence other companies in the commercial physical and biological research sector, as they also strive to meet Nasdaq's stringent listing requirements.
What's Next
The filing does not say what happens next.